Literature DB >> 8157119

Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord.

M H Tuszynski1, D A Peterson, J Ray, A Baird, Y Nakahara, F H Gage.   

Abstract

The influences of neurotrophic factors on adult mammalian spinal cords are incompletely understood. In the present experiment, we utilized somatic gene transfer to examine the effects of nerve growth factor (NGF) on the unlesioned spinal cords of adult Fischer rats. Fischer 344 rat primary fibroblasts were genetically modified in vitro to produce and secrete NGF, then grafted to spinal cords at the T7 level. Grafts survived in vivo for periods of up to 1 year, and induced an extremely robust ingrowth of spinal neurites. Control and basic fibroblast growth factor-producing grafts did not promote extensive neurite growth. Neurites penetrating the NGF grafts were of sensory origin, since they labeled immunocytochemically for calcitonin gene-related peptide but not markers of other neuronal transmitter phenotypes. Electron microscopy revealed that neurites within NGF-secreting grafts were enveloped in glial cell processes and that axons frequently became myelinated. These results indicate that (i) genetically modified cell grafts are a useful model for studying trophic factor effects in the adult mammalian spinal cord, (ii) sensory neurites maintain robust NGF responsiveness into adulthood, and (iii) sprouting neurites can follow glial channels and become myelinated in the adult spinal cord. Grafts of fibroblasts genetically modified to secrete trophic factors merit study as potential tools for promoting regeneration after spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157119     DOI: 10.1006/exnr.1994.1037

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  39 in total

Review 1.  Peripheral nerve regeneration and neurotrophic factors.

Authors:  G Terenghi
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

Review 2.  Molecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury.

Authors:  Erna A van Niekerk; Mark H Tuszynski; Paul Lu; Jennifer N Dulin
Journal:  Mol Cell Proteomics       Date:  2015-12-22       Impact factor: 5.911

Review 3.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

4.  Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury.

Authors:  R Grill; K Murai; A Blesch; F H Gage; M H Tuszynski
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 5.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

6.  Axonal regeneration of different tracts following transplants of human glial restricted progenitors into the injured spinal cord in rats.

Authors:  Ying Jin; Jed S Shumsky; Itzhak Fischer
Journal:  Brain Res       Date:  2018-02-01       Impact factor: 3.252

Review 7.  Growth factors and combinatorial therapies for CNS regeneration.

Authors:  Paul Lu; Mark H Tuszynski
Journal:  Exp Neurol       Date:  2007-08-22       Impact factor: 5.330

8.  Recovery of CNS pathway innervating the sciatic nerve following transplantation of human neural stem cells in rat spinal cord injury.

Authors:  Kwang-Bok Lee; Jung Hoon Choi; Kyunghee Byun; Kwang Hoon Chung; Ji Hyeon Ahn; Goo-Bo Jeong; In Koo Hwang; Seungup Kim; Moo-Ho Won; Bonghee Lee
Journal:  Cell Mol Neurobiol       Date:  2011-08-11       Impact factor: 5.046

9.  Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patients.

Authors:  Sherif M Amr; Ashraf Gouda; Wael T Koptan; Ahmad A Galal; Dina Sabry Abdel-Fattah; Laila A Rashed; Hazem M Atta; Mohammad T Abdel-Aziz
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

10.  Continuous brain-derived neurotrophic factor (BDNF) infusion after methylprednisolone treatment in severe spinal cord injury.

Authors:  Daniel H Kim; Tae-Ahn Jahng
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.